Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Rises By 5.0%

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the target of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 8,780,000 shares, an increase of 5.0% from the June 30th total of 8,360,000 shares. Based on an average trading volume of 1,540,000 shares, […]

Related Keywords

China ,Canada ,Stephen Davis ,Markc Schneyer ,Pharmaceuticals Daily ,Royal Bank ,Nisa Investment Advisors ,Nemes Rush Group ,China Universal Asset Management Co ,Nasdaq ,Acadia Pharmaceuticals Inc ,Cm Bidwell Associates Ltd ,Credit Suisse Group ,Pharmaceuticals Inc ,Pharmaceuticals Trading ,Get Free Report ,Suisse Group ,Universal Asset Management ,Rush Group ,Investment Advisors ,Acadia Pharmaceuticals ,Nasdaq Acad ,Facad ,Medical ,Stocks ,Options ,Put ,Call ,